“Adalimumab and Etanercept in the Treatment of Rheumatoid Arthritis and Spondyloarthropathies: Budget Impact Model of Dose Reduction ”. 2014. Journal of Pharmacy and Nutrition Sciences 4 (3): 170-76. https://doi.org/10.6000/1927-5951.2014.04.03.1.